AGP Executive Report
Last update: 7 hours agoMedical Policy Watch: Thailand’s cannabis rules have shifted again, moving from broad decriminalization toward a tightly regulated medical-only framework, with access now more specific for Bangkok dispensaries. Regulatory Oversight: Massachusetts’ Cannabis Control Commission completed a shelf audit of THC potency labels, flagging products that fall outside accurate ranges and moving to stop further sales of noncompliant flower. Enforcement & Compliance: Maryland cracked down on unlicensed cannabis sales in St. Mary’s County, seizing illicit flower and thousands of non-compliant THC products from three tobacco/smoke shops. Industry & Finance: Glass House Brands reported Q2 2026 results, highlighting record biomass production and continuing its 2026 outlook after deconsolidating its retail business. Public Safety: A UK court jailed a driver who fatally struck a woman while behind the wheel with cannabis in his system, underscoring ongoing risks around impaired driving. Business Deal: NFP (Aon) acquired Frontier Risk Group’s cannabis retail insurance business, expanding coverage for regulated cannabis operators. Research & Care: A study reports medical cannabis-based products improved endometriosis pain, sleep, and anxiety while reducing opioid use over 24 months.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[A conversation with Brian Coffman, Ph.D., about revisiting cannabis-associated psychosis as a potentially separate disorder from schizophrenia]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/27523011-934170696-bf7c871c4269c04962727a0c5f72eb54a870e548-1200x628-200x105.png)
